Pharmaceutical Chemistry Journal

, Volume 33, Issue 5, pp 232–243 | Cite as

Benzimidazole derivatives: Spectrum of pharmacological activity and toxicological properties (a review)

  • A. A. Spasov
  • I. N. Yozhitsa
  • L. I. Bugaeva
  • V. A. Anisimova
Search for New Drugs

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    F. Hobrecker,Ber. Dtsch. Chem. Ges., Berlin,5, 920–924 (1872).Google Scholar
  2. 2.
    D. Hodgkin, J. Pickworth, S. Robertson, et al.,Nature,176(4477), 325–328 (1955).PubMedCrossRefGoogle Scholar
  3. 3.
    J. Brown, D. Craig, and A. Kandel,Proc. Soc. Exp. Biol. Med.,83 (2), 408–411 (1953).PubMedGoogle Scholar
  4. 4.
    I. Tamm, K. Folkers, C. Shunk, et al.,J. Exp. Med.,98(3), 245–259 (1953).PubMedCrossRefGoogle Scholar
  5. 5.
    I. Tamm, M. Nemes, and S. Osterhout,J. Exp. Med.,111(3), 339–349 (1960).PubMedCrossRefGoogle Scholar
  6. 6.
    I. Tamm, R. Bablanian, M. Nemes, et al.,J. Exp. Med.,113(4), 625–655 (1961).PubMedCrossRefGoogle Scholar
  7. 7.
    B. C. Bishop, E. T. Chelton, and A. I. Jones,Biochem. Pharmacol.,13(5), 571–574 (1964).CrossRefGoogle Scholar
  8. 8.
    D. W. Woolley,J. Biol. Chem.,152(1), 225–232 (1944).Google Scholar
  9. 9.
    C. Hubschwerlen, P. Pflieger, J. L. Specklin, et al.,J. Med. Chem.,35(8), 1385–1392 (1992).PubMedCrossRefGoogle Scholar
  10. 10.
    J. Pernak, A. Skrzypezak, L. Michalak, et al.,Arch. Pharm. (Weinheim, Ger.),326(4), 237–240 (1993).Google Scholar
  11. 11.
    L. Mishra, V. K. Singh, N. K. Dubey, and A. K. Mishra,Biosci. Biotechnol. Biochem.,57(6), 989–991 (1993).PubMedCrossRefGoogle Scholar
  12. 12.
    P. Hrelia, M. Morotti, F. Vigagni, et al.,Farmaco,49(4), 303–304 (1994).Google Scholar
  13. 13.
    M. Pedini, G. De Meo, A. Ricci, et al.,Farmaco,49(4), 303–304 (1993).Google Scholar
  14. 14.
    R. W. Buckheit, M. G. Hollingshead, J. G. Decker, et al.,Antiviral. Res.,21(3), 247–265 (1993).PubMedCrossRefGoogle Scholar
  15. 15.
    S. M. el Darcer, K. F. Tillery, L. M. Rose, et al.,Drug Metab. Dispos.,21(2), 231–235 (1993).Google Scholar
  16. 16.
    P. L. Boyer, M. J. Currens, J. B. McMahon, et al.,J. Virol.,67(4), 2412–2420 (1993).PubMedGoogle Scholar
  17. 17.
    D. P. Green,J. Reprod. Fertil.,96(2), 581–591 (1992).PubMedCrossRefGoogle Scholar
  18. 18.
    A. Y. Chen, C. Yu, A. Bodley, et al.,Cancer Res.,53(6), 1332–1337 (1993).PubMedGoogle Scholar
  19. 19.
    M. F. Brana, J. M. Castellano, G. Keilhauer, et al.,Anticancer Drug Des.,9(6), 527–538 (1994).PubMedGoogle Scholar
  20. 20.
    A. Chimirri, S. Grasso, A. M. Montforte, et al.,Farmaco,49(5), 337–344 (1994).PubMedGoogle Scholar
  21. 21.
    S. B. Seredenin, Yu. G. Bobkov, A. D. Durnev, and O. Yu. Dubovskaya,Byull. Eksp. Biol. Med.,52(7), 76–79 (1986).Google Scholar
  22. 22.
    S. B. Seredenin and A. D. Durnev,Pharmacological Protection of Genome [in Russian], VINITI, Moscow (1992).Google Scholar
  23. 23.
    N. O. Daugel-Dauge, A. D. Durnev, A. V. Kulakova, et al.,Vestn. Ross. Akad. Med. Nauk,1, 29–38 (1995).Google Scholar
  24. 24.
    V. N. Zinov'eva, A. A. Spasov, O. V. Ostrovskii, et al.,Vestn. Volgograd. Med. Akad., No. 4, 34–38 (1998).Google Scholar
  25. 25.
    A. P. Chavarria, J. C. Swartzwelder, V. M. Villarejos, et al.,Am. J. Trop. Med. Hyg.,22, 592–595 (1973).PubMedGoogle Scholar
  26. 26.
    K. Maertens and M. Wery,Trans. Roy Soc. Trop. Med. Hyg.,69, 359–360 (1975).PubMedCrossRefGoogle Scholar
  27. 27.
    S. K. K. Seah,Can. Med. Assoc. J.,115, 777–779 (1976).PubMedGoogle Scholar
  28. 28.
    T. C. Beard, M. D. Rickard, and H. T. Goodman,Med. J. Aust.,1, 633–635 (1978).PubMedGoogle Scholar
  29. 29.
    P. Kern, M. Dietrich, and K. J. Volkmer:Tropenmed Parasitol.,30, 65–72 (1979).PubMedGoogle Scholar
  30. 30.
    J. S. Keystone and J. K. Murdoch,Ann. Int. Med.,91, 582–586 (1979).PubMedGoogle Scholar
  31. 31.
    A. E. Frol'tseva, N. D. Lychko, and M. N. Lebedeva,Med. Parazitol. Parazitar. Bolezni,3, 72–74 (1983).Google Scholar
  32. 32.
    W. H. Eyster, Jr.,Arch Dermatol.,95, 620–621 (1967).PubMedCrossRefGoogle Scholar
  33. 33.
    C. M. Davis and R. M. Israel,Arch. Dermatol.,97, 325–326 (1968).PubMedCrossRefGoogle Scholar
  34. 34.
    P. S. E. G. Harland, R. H. Meakins, and R. H. Harland,Br. Med. J.,2, 772 (1977).PubMedGoogle Scholar
  35. 35.
    J. M. Goldsmid and E. H. Froese,Cent. Afr. J. Med.,23, 250–251 (1977).PubMedGoogle Scholar
  36. 36.
    E. B. Scowden, W. Schaffner, and W. J. Stone,Medicine (Baltimore),57, 527–544 (1978).PubMedGoogle Scholar
  37. 37.
    S. C. Tolliver, E. T. Lyons, J. H. Drudge, et al.,Am. J. Vet. Res.,54(6), 908–913 (1993).PubMedGoogle Scholar
  38. 38.
    E. T. Lyons, J. H. Drudge, S. C. Tolliver, et al.,Vet. Parasitol.,52(3–4), 271–277 (1994).PubMedCrossRefGoogle Scholar
  39. 39.
    D. N. Ali and D. R. Hennessy,Int. J. Parasitol.,25(1), 71–74 (1995).PubMedCrossRefGoogle Scholar
  40. 40.
    H. T. Purvis, J. C. Whittier, S. L. Boyles, et al.,J. Anim. Sci.,72(4), 817–823 (1994).PubMedGoogle Scholar
  41. 41.
    J. Landuyt, M. Debackere, J. Vercruysse, and Q. McKellar,J. Vet. Pharmacol. Ther.,18(3), 180–186 (1995).PubMedGoogle Scholar
  42. 42.
    J. J. Vermunt, D. M. West, and W. E. Pomroy,Vet. Rec.,137(2), 43–45 (1995).PubMedGoogle Scholar
  43. 43.
    J. Surin,Southeast Asian J. Trop. Med. Public Health,26(1), 128–134 (1995).PubMedGoogle Scholar
  44. 44.
    I. A. Barger, J. W. Steel, and B. R. Rodden,Aust. Vet. J.,70(2), 41–48 (1995).Google Scholar
  45. 45.
    U. M. Morgan, J. A. Reynoldson, and R. C. Thompson,Antimicrob. Agents Chemother.,37(2), 328–331 (1993).PubMedGoogle Scholar
  46. 46.
    C. E. Lanusse, L. H. Gascon, and R. K. Prichard,J. Vet. Pharmacol. Ther.,18(3), 196–203 (1995).PubMedGoogle Scholar
  47. 47.
    A. W. Stitt, I. Fairweather, and R. O. Mackender,Int. J. Parasitol.,25(4), 421–429 (1995).PubMedCrossRefGoogle Scholar
  48. 48.
    A. W. Carr, R. O. McCracken, and W. H. Stillwell,J. Parasitol.,79(2), 198–204 (1993).PubMedCrossRefGoogle Scholar
  49. 49.
    S. N. Mahato, L. J. Harrison, J. A. Hammond,Vet. Rec.,135(24), 579–580 (1994).PubMedGoogle Scholar
  50. 50.
    E. T. Lyons, J. H. Drudge, S. C. Tolliver, and S. Stamper,Am. J. Vet. Res.,54(3), 406–410 (1993).PubMedGoogle Scholar
  51. 51.
    S. R. Stoitsova and L. N. Gorchilova,J. Helminthol.,68(1), 73–80 (1994).PubMedCrossRefGoogle Scholar
  52. 52.
    J. L. del Estal, M. L. A. Bujidos, R. B. Fouce, et al.,J. Pharm. Biomed. Anal.,12(11), 1471–1474 (1994).PubMedCrossRefGoogle Scholar
  53. 53.
    H. Q. Ying and X. F. Dai,Yao Hsueh. Hsueh. Pao,28(7), 553–556 (1993).PubMedGoogle Scholar
  54. 54.
    E. Ravina, R. S. Alonso, J. Fueyo, et al.,Arzneim. Forsch.,43(6), 689–694 (1993).Google Scholar
  55. 55.
    S. Watts, E. Rapson, A. Atrins, et al.,Biochem. Pharmacol.,31, 3035 (1982).PubMedCrossRefGoogle Scholar
  56. 56.
    B. A. Porai-Koshits, Sh. F. Ginzburg, and L. S. Éfros,Zh. Obshch. Khim.,17(10), 1768–1774 (1947).Google Scholar
  57. 57.
    E. N. Pavlova, O. N. Liberman, and S. V. Perova, in:Pharmacology of New Medicinal Preparations [in Russian], Nauka, Leningrad (1947), pp. 34–35.Google Scholar
  58. 58.
    N. N. Savitskii, in:Pharmacology of New Medicinal Preparations [in Russian], Nauka, Leningrad (1947), pp. 23–25.Google Scholar
  59. 59.
    N. A. Tolubeeva and S. A. Tseitlin, in:Pharmacology of New Medicinal Preparations [in Russian], Nauka, Leningrad (1947), pp. 36–38.Google Scholar
  60. 60.
    D. S. Paskov,Farmakol. Toksikol.,11(3), 18–22 (1948).Google Scholar
  61. 61.
    D. S. Paskov,Farmakol. Toksikol.,11(2), 20–26 (1948).Google Scholar
  62. 62.
    S. V. Anichkov,Novosti Med.,12, 1–21 (1949).Google Scholar
  63. 63.
    E.B. Derankova,Dibazole in the Prophylaxis and Treatment of Late Toxicosis in Pregnants [in Russian], Nauka, Leningrad (1961).Google Scholar
  64. 64.
    T. Ogihara, M. Nagano, H. Mikami, et al.,Clin. Ther.,16(1), 74–86 (1994).PubMedGoogle Scholar
  65. 65.
    Proc. 15th Sci. Meet. Int. Soc. Hypertension, Satellite Symp. “Angiotensin II Receptor Antagonists: Can They Go Beyond ACE Inhibitors?” (Melbourne, Australia, March 1994), Blood Press, Melbourne (1994), Suppl. 5, pp. 1–133.Google Scholar
  66. 66.
    X. C. Li and R. E. Widdop,Hypertension,26(6), 989–997 (1995).PubMedGoogle Scholar
  67. 67.
    E. Delacretaz, J. Nussberger, J. Biollaz, et al.,Hypertension,25(1), 14–21 (1995).PubMedGoogle Scholar
  68. 68.
    S. Kim, M. Kawamura, H. Wanibuchi, et al.,Circulation,92(1), 88–95 (1995).PubMedGoogle Scholar
  69. 69.
    G. Mehrke, X. G. Zong, V. Flockerzi, and F. Hofmann,J. Pharmacol. Exp. Ther.,271(3), 1483–1488 (1994).PubMedGoogle Scholar
  70. 70.
    R. S. Vander Heide, L. M. Schwartz, and K. A. Reimer,Cardiovasc. Res.,28(10), 1526–1532 (1994).CrossRefGoogle Scholar
  71. 71.
    J. Su, N. Renaud, A. Carayon, et al.,Br. J. Pharmacol.,113(2), 395–402 (1994).PubMedGoogle Scholar
  72. 72.
    A. Rutledge and D. J. Triggle,Eur. J. Pharmacol.,280(2), 155–158 (1995).PubMedCrossRefGoogle Scholar
  73. 73.
    Y. Sato, H. Watanabe, and N. Himori,Nippon Yakurigaku Zasshi,105(3), 171–176 (1995).PubMedGoogle Scholar
  74. 74.
    R. Gompper,Effenberger, Unbersnchungen in der Azolzeihe. XI. Synthese und Reaktionen der 2-Chloraxozole, Berlin (1959), Vol. 92, p. 1928.Google Scholar
  75. 75.
    G. V. Kovalev, A. A. Spasov, P. A. Bakumov, et al.,Abstracts of Papers. All-Union Conf. “Synthesis, Pharmacology, and Clinical Aspects of New Psychotropic and Cardiovascular Agents” [in Russian], Volgograd (1989), pp. 127–128.Google Scholar
  76. 76.
    G. V. Kovalev, A. A. Spasov, A. M. Simonov, et al.,Abstracts of Papers. The 3rd All-Union Symp. on the Targeted Search for New Physiologically Active Substances [in Russian], Riga (1979), p. 40.Google Scholar
  77. 77.
    A. M. Simonov, A. A. Belous, V. A. Anisimova, and S. V. Ivanovskaya,Khim.-Farm. Zh.,3(1), 7–10 (1969).Google Scholar
  78. 78.
    S. V. Ivanovskaya,Trudy Volgograd. Med. Inst.,21, 175–178 (1968).Google Scholar
  79. 79.
    S. V. Ivanovskaya,Cand. Sci. (Med.) Thesis [in Russian], Volgograd (1969).Google Scholar
  80. 80.
    G. V. Kovalev, S. M. Gofman, S. V. Ivanovskaya, et al.,Farmakol. Toksikol., No. 3, 232–237 (1973).Google Scholar
  81. 81.
    G. V. Kovalev, S. V. Ivanovskaya, S. M. Gofman, and V. I. Petrov,Abstracts of Papers. The 4th Volga Region Conf. Physiologists and Participation of Biochemists, Pharmacists, and Morphologists [in Russian], Cheboksary (1973), Vol. 2, p. 34.Google Scholar
  82. 82.
    A. A. Spasov,Author's Abstract of Cand. Sci. (Med.) Thesis [in Russian], Moscow (1975).Google Scholar
  83. 83.
    A. A. Spasov,Trudy Volgograd. Med. Inst.,30(3), 99–104 (1977).Google Scholar
  84. 84.
    G. V. Kovalev, A. A. Spasov, V. I. Porotikov, and T. G. Kvachenkova,Abstracts of Papers. The 2nd All-Union Symp. “Blood Circulation under High-Altitude and Experimental Hypoxia [in Russian], Frunze (1982).Google Scholar
  85. 85.
    A. A. Spasov and T. G. Kvachenkova,Problems in Clinical and Experimental Medicine [in Russian], Volgograd. Med. Inst., Volgograd (1979), pp. 50–51.Google Scholar
  86. 86.
    G. V. Kovalev, A. A. Spasov, S. A. Nikitin, et al., USSR Inventor's Certificate No. 976,665;Byull. Izobret., No. 7, 13–14 (1978).Google Scholar
  87. 87.
    T. I. Panchenko, G. V. Kovalev, and A. A. Spasov,Abstracts of Papers. The 3rd All-Union Conf. on Bioantioxidants [in Russian], Moscow (1982), Vol. 2, pp. 142–143.Google Scholar
  88. 88.
    L. M. Gaevaya,Abstracts of Papers, The 3rd Int. Conf. “Ecologic Pathology and Its Pharmacological Correction (Chita, 26–27 June, 1991) [in Russian], Chita (1991), Part 2, p. 119.Google Scholar
  89. 89.
    D. McTavish, M. M. T. Buckley, and R. C. Heel,Drugs,42, 138–170 (1991).PubMedGoogle Scholar
  90. 90.
    C. W. Howden,Clin. Pharmacokinet.,20, 38–49 (1991).PubMedGoogle Scholar
  91. 91.
    G. Massoomi, J. Savage, and C. J. Destache,Pharmacotherapy,13, 46–59 (1993).PubMedGoogle Scholar
  92. 92.
    R. D. Shamburek and M. L. Schubert,Balilliere's Clin. Gastroenterol.,7, 23–54 (1993).CrossRefGoogle Scholar
  93. 93.
    J. J. Kuiper,Am. J. Med.,95, 248 (1993).PubMedCrossRefGoogle Scholar
  94. 94.
    W. A. Belli and J. Fryklund,Antimicrob. Agents. Chemother.,39(8), 1717–1720 (1995).PubMedGoogle Scholar
  95. 95.
    H. Bliesath, R. Huber, M. Hartmann, et al.,Int. J. Clin. Pharmacol. Ther.,32(1), 44–50 (1994).PubMedGoogle Scholar
  96. 96.
    W. Schepp, M. Rehner, and L. Witzel,Aliment. Pharmacol. Ther.,8 (Suppl. 1), 53–57 (1994).PubMedGoogle Scholar
  97. 97.
    V. W. Steinijans, R. Huber, M. Hartmann, et al.,Int. J. Clin. Pharmacol. Ther.,32(8), 385–399 (1994).PubMedGoogle Scholar
  98. 98.
    H. G. Dammann, T. Bethke, F. Burkhardt, et al.,Aliment. Pharmacol. Ther.,8(5), 549–554 (1994).PubMedCrossRefGoogle Scholar
  99. 99.
    L. Witzel, H. Gutz, W. Huttemann, et al.,Aliment. Pharmacol. Ther.,9(1), 19–24 (1995).PubMedCrossRefGoogle Scholar
  100. 100.
    G. Sachs, J. M. Shin, C. Briving, et al.,Ann. Rev. Pharmacol. Toxicol.,35, 277–305 (1995).CrossRefGoogle Scholar
  101. 101.
    J. Mossner, A. H. Holscher, R. Herz and A. Schneider,Aliment. Pharmacol. Ther.,9(3), 321–326 (1995).PubMedCrossRefGoogle Scholar
  102. 102.
    G. T. Tucker,Aliment. Pharmacol. Ther.,8 (Suppl. 1), 33–38 (1994).PubMedGoogle Scholar
  103. 103.
    R. Arnold,Aliment. Pharmacol. Ther.,8 (Suppl. 1), 65–70 (1994).PubMedGoogle Scholar
  104. 104.
    T. Takimoto, K. Ido, Y. Taniguchi, et al.,J. Clin. Gastroenterol.,20 (Suppl. 2), 121–124 (1995).CrossRefGoogle Scholar
  105. 105.
    M. Masuda, A. Uchida, H. Matsukura, and T. Kamishiro,Nippon Yakurigaku Zasshi,104(4), 325–335 (1994).PubMedGoogle Scholar
  106. 106.
    K. Ishihara, T. Ichikawa, Y. Komuro, et al.,Arzneim. Forsch.,44(7), 827–830 (1994).Google Scholar
  107. 107.
    H. Matsukura, M. Masuda, A. Uchida, and T. Kamishiro,Nippon Yakurigaku Zasshi,104(2), 91–100 (1994).PubMedGoogle Scholar
  108. 108.
    A. A. Spasov,Abstracts of Papers. The 1st All-Russia Conf. “Mankind and Drugs” (Moscow, 12–16 April, 1992) [in Russian], Moscow (1992), Vol. 2, p. 447.Google Scholar
  109. 109.
    Astemizole—Another Non-Sedating Antihistamine,Lett Med. Drugs Ther.,31, 43–44 (1989).Google Scholar
  110. 110.
    Safety of Terfenadine and Astemizole,Med. Lett. Drugs Ther.,34, 9–10 (1992).Google Scholar
  111. 111.
    Treatment of Seasonal and Perennial Rhinitis,Br. J. Med.,283, 808–810 (1981).Google Scholar
  112. 112.
    T. G. Burke and A. H. MutnickAnn. Pharmacother,27, 239–241 (1993).PubMedGoogle Scholar
  113. 113.
    Janssen Pharmaceutica, Hismanal (Astemizole): Prescribing Information, in:Physicians Desk Reference (47th Edition), Medical Economics Company Inc., Montvale, NJ (1993).Google Scholar
  114. 114.
    Janssen Pharmaceutica,Hismanal (Astemizole): Clinical Monograph, Piscataway, NJ (1991).Google Scholar
  115. 115.
    D. M. Richards, R. N. Brogden, T. M. Heel, et al.,Drugs,28, 38–61 (1984).PubMedGoogle Scholar
  116. 116.
    P. Danjou, P. Molinier, I. Berlin, et al.,Br. J. Clin. Pharmacol.,34(4), 328–331 (1992).PubMedGoogle Scholar
  117. 117.
    E. F. Vuurman, M. M. Uiterwijk, P. Rosenzweig, et al.,Eur. J. Clin. Pharmacol.,47(3), 253–259 (1994).PubMedGoogle Scholar
  118. 118.
    J. Levrier, D. Duval, M. Prouteau, et al.,Arzneimit. Forsch.,45(5), 559–568 (1995).Google Scholar
  119. 119.
    J. Benavides, H. Schoemaker, C. Dana, et al.,Arzneimit. Forsch.,45(5), 551–558 (1995).Google Scholar
  120. 120.
    A. Patat, M. C. Perault, B. Vandel, et al.Br. J. Clin. Pharmacol.,39(1), 31–38 (1995).PubMedGoogle Scholar
  121. 121.
    J. M. Yanni, D. J. Stephens, D. W. Parnell, et al.,J. Ocul. Pharmacol.,10(4), 665–675 (1994).PubMedGoogle Scholar
  122. 122.
    N. A. Sharif, S. X. Su, and J. M. Yanni,J. Ocul. Pharmacol.,10(4), 653–664 (1994).PubMedCrossRefGoogle Scholar
  123. 123.
    G. I. Elmer, J. O. Pieper, S. R. Goldberg, and F. R. George,Psychopharmacology (Berlin),117(1), 23–31 (1995).CrossRefGoogle Scholar
  124. 124.
    P. Hyyatia and J. D. Sinclair,Psychopharmacology (Berlin),111(4), 409–414 (1993).CrossRefGoogle Scholar
  125. 125.
    T. F. Burke, J. H. Woods, J. W. Lewis, and F. Medzihradsky,J. Pharmacol. Exp. Ther.,271(2), 715–721 (1994).PubMedGoogle Scholar
  126. 126.
    M. Sala, D. Braida, P. Calcaterra, et al.,Eur. J. Pharmacol.,217(1), 37–41 (1992).PubMedCrossRefGoogle Scholar
  127. 127.
    T. Suzuki, F. R. George, and R. A. Meisch,Pharmacol. Biochem. Behav.,42(4), 579–586 (1992).PubMedCrossRefGoogle Scholar
  128. 128.
    W. Kuzmierkiewiez, H. Fox, and E. Hac,Pharmazie,40(4), 462–464 (1985).Google Scholar
  129. 129.
    K. Taniguchi, S. Shigenaga, et al.,Chem. Pharm. Bull. Tokyo,41(2), 301–309 (1993).PubMedGoogle Scholar
  130. 130.
    Merck, Sharpe, & Dohme,Mintezol: Prescribing Information, West Point, PA (1984).Google Scholar
  131. 131.
    J. D. Geratz, K. B. Pryzwansky, J. H. Schwab, et al.,Am. J. Pathol.,142(4), 1227–1237 (1993).Google Scholar
  132. 132.
    S. C. Gilman, R. P. Carlson, J. Chang, et al.,Agents Actions,17(1), 53–59 (1986).CrossRefGoogle Scholar
  133. 133.
    S. C. Gilman, R. P. Carlson, J. F. Daiels, et al.,Int. J. Immunopharm.,9(1), 9–16 (1987).CrossRefGoogle Scholar
  134. 134.
    G. V. Ershov,Abstracts of Papers. The 1st Interinstitution Scientific-Practical Conference of Students and Young Scientists of the Volgograd Region “Medicine, Public Health, Physical Culture and Sports (Volgograd, 5–9 December, 1994) [in Russian], Volgograd. Med. Akad., Volgograd (1994), pp. 8–9.Google Scholar
  135. 135.
    L. I. Ratnikova,Zh. Mikrobiol. Epidemiol. Immunobiol., No. 9, 56–58 (1991).PubMedGoogle Scholar
  136. 136.
    L. I. Ratnikova,Klin. Med.,7, 89–91 (1991).Google Scholar
  137. 137.
    S. M. Gofman and S. M. Ermilova,Trudy Volgograd. Med. Inst.,30(3), 180–185 (1977).Google Scholar
  138. 138.
    V. F. Dolgushina,Zh. Mikrobiol., Epidemiol., Immunobiol., No. 4, 56–58 (1991).Google Scholar
  139. 139.
    L. I. Ratnikova, in:Problems in Epidemiology, Immunology, and Diagnostics of Viral Infections: A Republic Collection of Scientific Papers [in Russian], Research Institute of Viral Infections, Sverdlovsk (1990), pp. 82–85.Google Scholar
  140. 140.
    V. I. Putintsev, T. V. Sysoikina, and L. G. Kozyr,Correction of Immune Disorders in Patients with Prebronchitis Diagnosis by Antihypoxant Bemithyl [in Russian], Medical Institute, Lugansk (1993), p. 5.Google Scholar
  141. 141.
    P. E. Alashaev,Abstracts of Papers. Sci. Conf. Military Medical Academy [in Russia], Leningrad (1957), pp. 3–4.Google Scholar
  142. 142.
    B. A. ChirkovAbstracts of Papers. Sci. Conf. Military Medical Academy [in Russia], Leningrad (1959), pp. 145–146.Google Scholar
  143. 143.
    B. A. Chirkov,Farmakol. Toksikol.,23(5), 455–458 (1960).PubMedGoogle Scholar
  144. 144.
    A. M. Kapitanenko,Abstracts of Papers. Sci. Conf. Military Medical Academy [in Russia], Leningrad (1957), pp. 46–47.Google Scholar
  145. 145.
    A. M. Kapitanenko,Vrachebn. Delo,7, 713–714 (1958).Google Scholar
  146. 146.
    G. P. Dudchenko, A. A. Spasov, V. A. Anisimova, et al., in:Fundamental Investigations—a Basis for Drug Creation. Abstracts of Papers. The 1st Meet. All-Russia Sci. Soc. Pharmacists (Volgograd, 9–13 October, 1995) [in Russian], Moscow (1995).Google Scholar
  147. 147.
    A. A. Spasov, G. P. Dudchenko A. F. Turchaeva, et al.,Vestn. Volgograd. Med. Akad., No. 1, 33–36 (1995).Google Scholar
  148. 148.
    T. B. Sibiryakova, A. F. Turchaeva, and É. V. Besedina,Current Problems in Medicine, Proc. 49th Sci. Session [in Russian], Volgograd (1995), pp. 79–80.Google Scholar
  149. 149.
    T. B. Sibiryakova, P. A. Bakumov, N. P. Larionov, and A. A. Spasov,Abstracts of Papers. All-Russia Sci. Conf. “Creation of Drugs” (Moscow, 26–30 October, 1996) [in Russian], Moscow (1996), pp. 171–172.Google Scholar
  150. 150.
    G. Rusu, G. Danila, and M. Nechifor,Rev. Med. Chir. Soc. Med. Nat. Iasi.,97(2), 269–271 (1993).PubMedGoogle Scholar
  151. 151.
    S. M. Yung,Thromb. Res.,23(4–5), 401–410 (1981).Google Scholar
  152. 152.
    T. M. Plotnikova, Z. V. Kulakova, and M. B. Plotnikov,Byull. Eksp. Biol. Med.,111(4), 386–388 (1991).Google Scholar
  153. 153.
    T. M. Plotnikova, N. N. Firsov, and O. E. Vaizova,Eksp. Klin. Farmakol.,55(4), 29–31 (1992).PubMedGoogle Scholar
  154. 154.
    O. E. Vaizova, T. M. Plotnikova, and M. B. Plotnikov,Eksp. Klin. Farmakol.,57(1), 25–27 (1994).PubMedGoogle Scholar
  155. 155.
    M. A. Rozin,Pharmacology of Pathological Processes [in Russian], Nauka, Leningrad (1951), pp. 269–290.Google Scholar
  156. 156.
    M. A. Rozin,Farmakol. Toksikol.,14(1), 21–22 (1951).Google Scholar
  157. 157.
    M. A. Rozin,Proc. Sci. Meet. on Experimental Study of and Clinical Testing of Dimezole [in Russian], Leningrad (1961), pp. 5–10.Google Scholar
  158. 158.
    M. A. Rozin,Protein Synthesis and Cell Resistance [in Russian], Nauka, Leningrad (1951), pp. 3–6.Google Scholar
  159. 159.
    N. V. Lazarev and M. A. Rozin,Sov. Med.,4, 24–26 (1951).PubMedGoogle Scholar
  160. 160.
    N. N. Anosov and M. A. Rozin,Proserine, Eserine, Dibazole, and Their Application in Neuropathology [in Russian], Nauka, Leningrad (1956).Google Scholar
  161. 161.
    Yu. Yu. Zil'bert,Proc. 7th. Sci. Conf. Naval Medical Academy [in Russian], Leningrad (1953), p. 190.Google Scholar
  162. 162.
    M. Ya. Mikhel'son and Ya. P. Savinskii,Farmakol. Toksikol., No. 3, 28 (1955).Google Scholar
  163. 163.
    J. M. Sigh,J. Med. Chem.,12, 962 (1969).CrossRefGoogle Scholar
  164. 164.
    B. E. Maryanoff, W. Ho, D. McComsey, et al.,J. Med. Chem.,38(1), 16–20 (1995).PubMedCrossRefGoogle Scholar
  165. 165.
    M. N. Yarkova, Yu. A. Blednov, and S. B. Seredenin,Proc. Int. Conf. “Biological Basis of Individual Sensitivity to Psychotropic Drugs” (Moscow, 22–26 May, 1993), Moscow (1993), p. 151.Google Scholar
  166. 166.
    M. A. Yarkova, Yu. A. Blednov, and S. B. Seredenin, in:Actual Problems in Experimental and Clinical Pharmacology [in Russian], Smolensk Obl. Tipogr., Smolensk (1994), pp. 139–140.Google Scholar
  167. 167.
    S. B. Seredenin and M. A. Yarkova,RF Patent Application No. 94,022,663; Byul. Izobret., No. 6, 11–12 (1995).Google Scholar
  168. 168.
    E. I. Bakhareva,Author's Abstract of Doctoral (Biol. Sci.) Thesis [in Russian], Moscow (1995).Google Scholar
  169. 169.
    E. V. Avdeeva,Fundamental Investigations—a Basis for Drug Creation. Abstracts of Papers. The 1st Meet. All-Russia Sci. Soc. Pharmacists (Volgograd, 9–13 October, 1995) [in Russian], Moscow (1995), p. 7.Google Scholar
  170. 170.
    M. P. Martres, M. Baudry, and J. Ch. Schwartz,Life Sci.,23, 1781–1784 (1978).PubMedCrossRefGoogle Scholar
  171. 171.
    B. Costall, D. H. Fortune, and R. J. Naylor,J. Pharm. Pharmacol.,31, 344–347 (1979).PubMedGoogle Scholar
  172. 172.
    Y. Agid,Rev. Neurol.,137,(1), 49–51 (1981).PubMedGoogle Scholar
  173. 173.
    J. P. Bercovici,Nouv. Presse Med.,10(29), 2421–2425 (1981).PubMedGoogle Scholar
  174. 174.
    J. M. Van Nueten, C. Ennis, L. Helser, et al.,Life Sci.,23(5), 453–457 (1978).PubMedCrossRefGoogle Scholar
  175. 175.
    B. Cox and C. Ennis,Br. J. Pharmacol.,71, 177–184 (1980).PubMedGoogle Scholar
  176. 176.
    B. Costall, R. J. Naylor, and H. A. Sahyoun,Br. J. Pharmacol.,73, 312 (1981).Google Scholar
  177. 177.
    R. Gorich, T. R. Weihrauch, and H. Kilbinger,Arch. Pharmacol.,318, 308–312 (1982).CrossRefGoogle Scholar
  178. 178.
    P. A. J. Janssen and F. T. N. Allewijn,Arzneim. Forsch.,19, 279–282 (1968).Google Scholar
  179. 179.
    P. A. J. Janssen, C. J. E. Niemegeers, K. H. L. Schellekens, et al.,Arzneim. Forsch.,18, 261–279 (1968).Google Scholar
  180. 180.
    R. M. Pinder, R. N. Brogden P. R. Sawyer, et al.,Drugs,12, 1–40 (1976).PubMedCrossRefGoogle Scholar
  181. 181.
    McNeil Pharmaceutical,Orap (Pimozide) Tablets: Hospital formulary Information, Spring House, PA (1984).Google Scholar
  182. 182.
    McNeil Pharmaceutical, Orap: Prescribing Information, in: C. M. E. Krough (ed.),Compendium of Pharmaceuticals and Specialties (26th Ed.), Canadian Pharmaceutical Association, Toronto (1986), p. 546.Google Scholar
  183. 183.
    Lemmon Company,Orap (Pimozide): Prescribing Information, Sellersville, PA (1988).Google Scholar
  184. 184.
    M. H. Van Woert, D. Rosenbaum, and S. J. Enna, in:Gilles de la Tourette Syndrome, A. J. Friedhoff and T. N. Chase (eds.), Raven Press, New York (1982), pp. 369–375.Google Scholar
  185. 185.
    P. Seeman and T. Lee,Science,188, 1217–1219 (1975).PubMedCrossRefGoogle Scholar
  186. 186.
    H. Nyback, J. Schubert, and G. Sedvall,J. Pharm. Pharmacol.,22, 622–624 (1970).PubMedGoogle Scholar
  187. 187.
    N. E. Anden, S. G. Butcher, H. Corrodi, et al.,Eur. J. Pharmacol.,11, 303–314 (1970).PubMedCrossRefGoogle Scholar
  188. 188.
    L. E. Jonsson,Eur. J. Clin. Pharmacol.,4, 206–211 (1972).CrossRefGoogle Scholar
  189. 189.
    M. Gowardman, B. Barrer, and R. A. Brown,N. Z. Med. J.,78, 487–491 (1973).PubMedGoogle Scholar
  190. 190.
    E. L. Denijs and J. L. T. M. Vereecken,Psychiatr. Neurol. Neurochir.,76, 47–59 (1973).PubMedGoogle Scholar
  191. 191.
    F. Fline, R. W. Burgoyne, and J. Yamamoto,Curr. Ther. Res.,21, 768–778 (1977).Google Scholar
  192. 192.
    J. Rotrosen, M. B. Wallach, B. Angrist, et al.,Psychopharmacologia,26, 185–194 (1972).PubMedCrossRefGoogle Scholar
  193. 193.
    Yu. G. Bobkov, V. M. Vinogradov, V. F. Katkov, et al.,Pharmacological Correction of Fatigue [in Russian], Meditsina, Moscow (1984), p. 208.Google Scholar
  194. 194.
    A. V. Smirnov,Pharmacological Means of Increasing the Working Capacity [in Russian], Military Medical Academy, Leningrad (1984), pp. 31–35.Google Scholar
  195. 195.
    Yu. G. Bobkov, V. M. Vinogradov, and A. V. Smirnov,Abstract of Papers. The 4th All-Union Symp. on Targeted Search for Physiologically Active Substances [in Russian], Riga (1981), p. 57.Google Scholar
  196. 196.
    V. M. Vinogradov and A. T. Grechko,Farmakol. Toksikol., No. 8, 5–9 (1982).Google Scholar
  197. 197.
    Yu. G. Bobkov and V. M. Vinogradov,Pharmacological Regulation of Fatigue Processes [in Russian], Meditsina, Moscow (1982), pp. 7–33.Google Scholar
  198. 198.
    Yu. G. Bobkov, Yu. I. Morozov, and A. I. Machula,Patol. Fiziol. Eksp. Terap.,2, 39–41 (1990).Google Scholar
  199. 199.
    A. V. Smirnov,Abstracts of Papers. The 1st All-Russia Congr. “Mankind and Drugs” (Moscow, 12–16 April, 1992) [in Russian], Moscow (1992), p. 419.Google Scholar
  200. 200.
    Yu. A. Aleksandrovskii,Organization of Psychic Aid and Therapy of Victims during and after Earthquakes [in Russian], Meditsina, Moscow (1989).Google Scholar
  201. 201.
    Yu. A. Aleksandrovskii, O. S. Lobastov, L. I. Spivak, and B. P. Shchukin,Psychogenesis under Extremal Conditions, [in Russian], Meditsina, Moscow (1991).Google Scholar
  202. 202.
    A. A. Viru,Adrenal Cortex Function during Muscular Activity [in Russian], Meditsina, Moscow (1977).Google Scholar
  203. 203.
    A. A. Viru,Hormonal Mechanisms of Adaptation and Training [in Russian], Nauka, Leningrad (1981).Google Scholar
  204. 204.
    M. B. Plotnikov, A. S. Saratikov, T. M. Plotnikova, et al.,Byull. Eksp. Biol. Med.,107(5), 583–585 (1989).Google Scholar
  205. 205.
    A. V. Tsibanev,Abstracts of Papers. The 1st All-Russia Congr. “Mankind and Drugs” (Moscow, 12–16 April, 1992) [in Russian], Moscow (1992), p. 421.Google Scholar
  206. 206.
    V. A. Kosolapov, V. A. Ostrovskii, and A. A. SpasovEksp. Klin. Farmakol.,59(6), 51–53 (1996).PubMedGoogle Scholar
  207. 207.
    V. A. Kosolapov, V. V. Drozd, V. A. Ostrovskii, and A. A. Spasov, in:Problems in Medicine of Disasters [in Russian], E. A. Vagner (ed.), Perm Gos. Med. Akad., Rerm (1993), Part II, pp. 308–310.Google Scholar
  208. 208.
    A. A. Shipov, A. A. Spasov, V. A. Ostrovskii, and A. Ya. Pocheptsov, in:Problems in Medicine of Disasters [in Russian], E. A. Vagner (ed.), Perm Gos. Med. Akad, Perm (1993), Part II, pp. 260–264.Google Scholar
  209. 209.
    V. A. Ostrovskii, A. A. Shipov, A. A. Spasov, et al.,Abstracts of Papers. The 1st All-Russia Congr. “Mankind and Drugs” (Moscow, 12–16 April, 1992) [in Russian], Moscow (1992), p. 421.Google Scholar
  210. 210.
    C. A. Rizzi, A. Prudentino, and E. Giraldo,Arzneimit. Forsch.,43(10), 1033–1041 (1993).Google Scholar
  211. 211.
    VIDAL Handbook. Drugs in Russia [in Russian], Astra-FarmServis, Moscow (1995), p. 1168.Google Scholar
  212. 212.
    T. Wada, Y. Inada, and T. Sanada,Eur. J. Pharmacol.,253(1–2), 27–34 (1994).PubMedCrossRefGoogle Scholar
  213. 213.
    D. C. Norford, D. J. Meuten, J. M. Cullen, et al.,Toxicol. Pathol.,21(5), 456–464 (1993).PubMedCrossRefGoogle Scholar
  214. 214.
    Merck & Co., Inc.,Prilosec (Omeprazole) Delayed Release Capsules: Prescribing Information, West Point, PA (1993).Google Scholar
  215. 215.
    M. H. Levin, R. A. Weinstein, J. L. Axelrod, et al.,J. Am. Med. Acad.,249, 2929–2931 (1983).Google Scholar
  216. 216.
    P. F. Miskovitz and N. B. Javitt,Am. J. Trop. Med. Hyg.,29, 1356–1358 (1980).PubMedGoogle Scholar
  217. 217.
    A. Z. Prikhod'ko and E. I. AstashkinKhim.-Farm. Zh.,26(3), 22–25 (1992).Google Scholar
  218. 218.
    I. R. Barilyak,Fiziol. Akt. Veshchestva,6, 85–88 (1974).Google Scholar
  219. 219.
    I. R. Barilyak,Fiziol. Akt. Veshchestva,8, 106–108 (1976).Google Scholar
  220. 220.
    T. Yamano, T. Noda, M. Shimizu, et al.,Fundam. Appl. Toxicol.,25, 218–223 (1995).PubMedCrossRefGoogle Scholar
  221. 221.
    K. S. Khera,Teratology,7, 243–252 (1973).CrossRefGoogle Scholar
  222. 222.
    J. A. Ruddick and K. S. Khera,Teratology,12, 277–282 (1975).PubMedCrossRefGoogle Scholar
  223. 223.
    S. D. Carter and J. W. Laskey,Toxicol. Lett.,11, 87–94 (1982).PubMedCrossRefGoogle Scholar
  224. 224.
    S. D. Carter, R. A. Hess, and J. W. Laskey,Biol. Reprod.,37, 709–717 (1987).PubMedCrossRefGoogle Scholar
  225. 225.
    T. V. Pastushenkov,Gigiena Sanit.,7, 83–85 (1983).Google Scholar
  226. 226.
    A. Janardhan, P. B. Sattur, and P. Sisodia,Bull. Environ. Contam. Toxicol.,33, 257–263 (1987).CrossRefGoogle Scholar
  227. 227.
    R. J. Kavlock, N. Chernoff, L.E. Gray Jr., et al.,Toxicol. Appl. Pharmacol.,62, 44–54 (1982).PubMedCrossRefGoogle Scholar
  228. 228.
    A. M. Cummings, M. T. Ebron-McCoy, J. M. Rogers, et al.,Fundam. Appl. Toxicol.,18, 288–293 (1992).PubMedCrossRefGoogle Scholar
  229. 229.
    W. A. M. Duncan, Ph. G. Lemon, and A. K. Palmer,Cornell Vet.,64 (Suppl. 4), 5–6 (1974).Google Scholar
  230. 230.
    L. I. Bugaeva A. A. Spasov, I. N. Yozhitsa, et al.,Vestn. Volgograd. Med. Akad., No. 1, 23–27 (1996).Google Scholar
  231. 231.
    A. A. Spasov, L. I. Bugaeva, I. N. Yozhitsa, et al.,Abstracts of Papers. The 3rd All-Russia Congr. “Mankind and Drugs” (Moscow, 16–20 April, 1996) [in Russian], Moscow (1996), p. 288.Google Scholar
  232. 232.
    A. A. Spasov, L. I. Bugaeva, I. N. Yozhitsa, et al.,Abstracts of Papers. The 14th Int. Symp. Medical Chemistry (Maastricht, Netherlands, 8–12 September, 1996), N. Abstr. P-6.26.Google Scholar
  233. 233.
    R. E. Goncharova and A. V. Leniva,Izv. Akad. Nauk BSSR, Ser. Biol. Nauk, No. 3, 44–48 (1980).Google Scholar
  234. 234.
    G. Sciler,Mutat. Res.,15(3), 237–236 (1972).Google Scholar
  235. 235.
    E. S. Selezneva, Z. P. Belousova, L. A. Gusak, et al.,Khim.-Farm. Zh.,26(3), 59–62 (1992).Google Scholar
  236. 236.
    J. P. Seiler,Mutat. Res.,15, 273–276 (1972).PubMedGoogle Scholar
  237. 237.
    A. M. Sarrif, G. T. Arce, and D. F. Khahn,Mutat. Res.,321(1–2), 43–56 (1994).PubMedGoogle Scholar
  238. 238.
    J. P. Seiler,Mutat. Res.,40, 339–348(1976).PubMedCrossRefGoogle Scholar
  239. 239.
    J. A. Styles and A. Garner,Mutat. Res.,26, 177–187 (1974).PubMedGoogle Scholar
  240. 240.
    R. Barale, C. Scapoli, C. Meli, et al.,Mutat. Res.,300(1), 15–28 (1993).PubMedCrossRefGoogle Scholar
  241. 241.
    P. Van Hummelen, A. Elhajouji, and M. Kirsch Volders,Mutagenesis,10(1), 23–29 (1995).PubMedGoogle Scholar
  242. 242.
    S. B. Seredenin,Abstracts of Papers. The 3rd All-Union Conf. on Pharmacokinetics “Present-Day State and Prospects of Pharmacokinetics” (Moscow, 18–19 December, 1991) [in Russian], Moscow (1991), p. 49.Google Scholar
  243. 243.
    A. D. Durnev and S. B. Seredenin,Khim.-Farm. Zh.,24 (2), 92–100 (1990).Google Scholar
  244. 244.
    G. J. Russell, J. H. Gill, and E. Lacey,Biochem. Pharmacol.,43(5), 1095–1100 (1992).PubMedCrossRefGoogle Scholar
  245. 245.
    S. G. Whittaker and E. M. Faustman,Toxicol. Appl. Pharmacol.,113(1), 144–151 (1992).PubMedCrossRefGoogle Scholar
  246. 246.
    A. Anumonye, T. Onibuwe-Johnson, and A. A. Marinho,W. Afr. J. Pharmacol. Drug. Res.,2, 17–24 (1976).Google Scholar
  247. 247.
    C. S. Stier, A. Elizur, A. Yeret, et al.,Curr. Ther. Res.,23, 632–641 (1978).Google Scholar
  248. 248.
    Pimozide for Tourette's Disorder,Med. Lett. Drugs Ther,27, 3–4 (1985).Google Scholar
  249. 249.
    N. Pitsikas, A. Brambilla, and F. Borsini,Pharmacol. Biochem. Behav.,47(1), 95–99 (1994).PubMedCrossRefGoogle Scholar
  250. 250.
    D. W. Bonhaus, D. N. Loury, L. B. Jakeman, et al.,J. Pharmacol. Exp. Ther.,267(2), 961–970 (1993).PubMedGoogle Scholar
  251. 251.
    T. Kamato, H. Ito, T. Suzuki, et al.,Jpn. J. Pharmacol.,67(3), 185–194 (1995).PubMedGoogle Scholar
  252. 252.
    P. G. McLean, I. M. Coupar, and P. Molenaar,Med. J. Aust.,159(11–12), 834 (1993).PubMedGoogle Scholar
  253. 253.
    J. C. Van Meel, W. Diederen, R. Haigh, et al.,Eur. J. Pharmacol.,233(2–3), 295–297 (1993).PubMedCrossRefGoogle Scholar
  254. 254.
    K. A. Wardle, E. S. Ellis, G. S. Baxter, et al.,Br. J. Pharmacol.,112(3), 789–794 (1994).PubMedGoogle Scholar
  255. 255.
    S. L. Lacasa,Eur. J. Biochem.,146(2), 339 (1985).PubMedCrossRefGoogle Scholar
  256. 256.
    S. L. Lacasa,J. Lipid Res.,27(4), 368 (1986).PubMedGoogle Scholar
  257. 257.
    J. J. Anderson, S. Kuo, T. N. Chase, and T. M. Engber,J. Pharmacol. Exp. Ther.,269(3), 1144–1151 (1994).PubMedGoogle Scholar
  258. 258.
    B. S. Sachais and J. E. Krause,Mol. Pharmacol.,46(1), 122–128 (1994).PubMedGoogle Scholar
  259. 259.
    L. Pradier, E. Habert Ortoli, L. Emile, et al.,Mol. Pharmacol.,47(2), 314–321 (1995).PubMedGoogle Scholar
  260. 260.
    A. J. Sellers and M. L. Ashford,Br. J. Pharmacol.,113(3), 659–661 (1994).PubMedGoogle Scholar
  261. 261.
    S. P. Olesen, E. Munch, P. Moldt, and J. Drejer,Eur. J. Pharmacol.,251(1), 53–59 (1994).PubMedCrossRefGoogle Scholar
  262. 262.
    K. Lee, I. C. Rowe, and M. L. Ashford,Eur. J. Pharmacol.,280(2), 215–219 (1995).PubMedCrossRefGoogle Scholar
  263. 263.
    X. Xu, T. D. Tsai, J. Wang, et al.,J. Pharmacol. Exp. Ther.,1(1), 362–369 (1994).Google Scholar
  264. 264.
    H. Satoh, T. Kobayashi, K. Higo, and A. Karasawa,Jpn. J. Pharmacol.,65(1), 45–50 (1994).PubMedGoogle Scholar
  265. 265.
    M. Kawakage, K. Sato, and A. Karasawa,Jpn. J. Pharmacol.,65(2), 163–166 (1994).PubMedGoogle Scholar
  266. 266.
    S. Shirakura, K. Higo, M. Takeda, and A. Karasawa,Jpn. J. Pharmacol.,65(2), 93–98 (1994).PubMedGoogle Scholar
  267. 267.
    K. Higo and A. Karasawa,Jpn. J. Pharmacol.,66(4), 471–479 (1994).PubMedGoogle Scholar
  268. 268.
    A. Welling, L. Lacinova, K. Donatin, et al.,Pflugers Arch.,429(3), 400–411 (1995).PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic/Plenum Publishers 1999

Authors and Affiliations

  • A. A. Spasov
    • 1
  • I. N. Yozhitsa
    • 1
  • L. I. Bugaeva
    • 1
  • V. A. Anisimova
    • 1
  1. 1.State Medical AcademyVolgogradRussia

Personalised recommendations